British journal of haematology
Risk factors and reasons for switching from front-line therapy in the Italian chronic myeloid leukaemia network: A cohort study.
Massimo Breccia, Valentina Giai, Tiziana Rosso, Patrizia Pregno, Fausto Castagnetti, Massimiliano Bonifacio, Isabella Capodanno, Mario Tiribelli, Fabio Stagno, Olga Mulas, Antonella Gozzini, Andrea Patriarca, Federica Sorà, Giuseppina Loglisci, Antonella Russo Rossi
Published: 202610.1111/bjh.70332
Abstract
Identifying chronic myeloid leukaemia (CML) patients at risk of therapeutic switch remains debated. We analysed the cumulative risk of treatment change in the CML Italian network prospective cohort based on first-line tyrosine kinase inhibitors and p…
Preview only. Read the full abstract at the source